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Catheter ablation has an important role in the management of patients with ventricular tachycardia (VT) but is limited by modest long-
term success rates. Magnetic resonance imaging (MRI) can provide valuable anatomic and functional information as well as potentially
improve identification of target sites for ablation. A major limitation of current MRI protocols is the spatial resolution required to identify
the areas of tissue responsible for VT but recent developments have led to new strategies which may improve substrate assessment.
Potential ways in which detailed information gained from MRI may be utilized during electrophysiology procedures include image integra-
tion or performing a procedure under real-time MRI guidance. Image integration allows pre-procedural magnetic resonance (MR) images
to be registered with electroanatomical maps to help guide VT ablation and has shown promise in preliminary studies. However, multiple
errors can arise during this process due to the registration technique used, changes in ventricular geometry between the time of MRI and
the ablation procedure, respiratory and cardiac motion. As isthmus sites may only be a few millimetres wide, reducing these errors may
be critical to improve outcomes in VT ablation. Real-time MR-guided intervention has emerged as an alternative solution to address the
limitations of pre-acquired imaging to guide ablation. There is now a growing body of literature describing the feasibility, techniques, and
potential applications of real-time MR-guided electrophysiology. We review whether real-time MR-guided intervention could be applied in
the setting of VT ablation and the potential challenges that need to be overcome.
...................................................................................................................................................................................................
Keywords Ventricular tachycardia • Cardiac magnetic resonance imaging • Substrate • Catheter ablation • Real
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Introduction
The majority of sudden cardiac deaths can be attributed to
ventricular tachycardia (VT) or ventricular fibrillation.1 Ventricular
tachycardia in the presence of structural heart disease (SHD) fre-
quently involves re-entry around or within a region of scar. Dense
scar may be caused by a previous myocardial infarction in ischaemic
cardiomyopathy (ICM) whilst diffuse fibrosis may be present in non-
ischaemic cardiomyopathy (NICM).2 Radiofrequency (RF) catheter
ablation has emerged as a promising management strategy and can
reduce recurrences of VT and appropriate implantable cardioverter-
defibrillator (ICD) therapies in patients with both ICM3,4 and NICM.5
However, VT ablation in SHD can be associated with significant com-
plications and modest long-term success rates.6 The standard
approach to VT ablation uses electroanatomical mapping (EAM) and
electrogram-defined surrogates of abnormal myocardium to target
the regions potentially capable of sustaining re-entry. There are sev-
eral limitations to this approach including the inability to interrogate
the complex 3D geometry of scar, limited spatial resolution of
voltage-based mapping, and failure to perform activation mapping
during unstable arrhythmias without haemodynamic support.7
There is a clinical need to improve the efficacy of catheter ablation
for VT. In this context, magnetic resonance imaging (MRI) could play
a role in the optimization of VT ablation. Scar and scar borderzone
(BZ) are 3D structures—MRI using late gadolinium enhancement
(LGE) is the best available technique to define scar in 3D and is a
powerful predictor of ventricular arrhythmia risk.8 Although MRI has
value in patients with idiopathic VT,9,10 its usefulness in patients with
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SHD is more pronounced. In this article, we assess the role of MRI
for the identification of substrate causing VT in SHD. We review the
use of image integration to guide VT ablation and potential limitations
of this strategy. An alternative approach to utilizing the benefits of
imaging is real-time magnetic resonance (MR)-guided intervention.
We assess whether real-time MRI-guided electrophysiology could
play a role in VT ablation and the challenges that need to be over-
come to make this a reality.
Magnetic resonance imaging to
identify the structural substrate
for ventricular tachycardia
The presence of scar detected using LGE-MRI is an independent
predictor of sudden cardiac death, recurrent VT, or appropriate ICD
discharge in patients with a history of sustained or non-sustained
VT.11 However, some types of scar may be more arrhythmogenic
than others.
The presence of heterogeneous tissue at the BZ regions between
scar and normal myocardium has been more frequently observed in
patients with VT compared to patients without VT matched for age,
sex, infarct location, and left ventricular ejection fraction.12 The chal-
lenge for MR is to enable accurate discrimination of arrhythmogenic
from non-arrhythmogenic scar. Different characteristics of scar such
as the location, signal intensity (SI), transmurality, shape, and com-
plexity have all been related to the substrate for VT.
There are subtle aspects of a VT isthmus, however, that can only
presently be defined using EAM including entry and exit-sites. The
common channel isthmus of VT circuits may also be formed by func-
tional rather than fixed lines of block whilst barriers forming the isth-
mus may not be clearly visible during sinus rhythm.13 It thus seems
unlikely that MRI may be able to define characteristics of an isthmus
using structural criteria alone but may augment the identification of
arrhythmogenic substrate when EAM may be equivocal.
Scar transmurality
The transmurality of scar has been co-localized to local electrogram
characteristics, however, the relationship remains incompletely
understood. A mismatch between infarct surface area measurements
on MRI-reconstructed images and EAM using a <1.5 mV bipolar volt-
age cut-off has been reported in 33% of cases. The areas of mismatch
occurred in regions such as the basal left ventricular septum or the
posterior wall where achievement of catheter stability and adequate
tissue contact may be more challenging during EAM.14
Critical sites for maintenance of VT have been confined to areas of
scar with >75% transmurality and in core–BZ transition sites15 whilst
regions of slow conduction with a stimulus-QRS time (S-QRS)
>40 ms have also been associated with regions of scar with >75%
transmurality.16 The complementary use of MRI could therefore
allow improved identification of scar and scar depth that may not be
well assessed using EAM alone.
Scar localization
Endocardial bipolar voltage mapping with its limited field of view
could miss epicardial substrate17 whilst the additive use of MRI for
substrate localization could improve the sensitivity and specificity of
predicting an epicardial origin for ventricular arrhythmia in NICM.18
Epicardial mapping can be challenging due to the presence of fat
affecting the quality of recorded bipolar electrograms or may even be
inaccessible due to the presence of pericardial adhesions.19 Magnetic
resonance imaging could therefore provide detailed information on
scar location non-invasively that could be used to determine access
and ablation strategies.
Signal intensity and complexity of scar
The voxel SI of scar on MR images has been used to differentiate
between core areas of scar and BZ regions of scar. Using pixel SI
thresholds of 60% and 40% of maximum SI to define the distribution
of core scar and BZ regions, critical sites for clinical VTs have been
identified on MRI when compared with EAM,20 albeit with significant
false positive rates.21 In a chronic porcine infarct model, areas of grey-
zone (BZ) quantified using LGE-MRI exhibited abnormal potentials
more frequently than healthy tissue or dense infarct during right ven-
tricular pacing.22 Recently, a new measure of scar inhomogeneity—
‘entropy’ of the probability of distribution of SI within scar tissue has
been found to be associated with VT burden independent of total
scar and left ventricular ejection fraction.23 Such measures may prove
to be promising discriminators between arrhythmogenic and non-
arrhythmogenic scars.
Insights from high resolution ex vivo
imaging
Whether MRI can accurately identify the specific regions of tissue that
participate in the VT circuit remains an open question. Using the
RhythmiaTM high-resolution mapping system in a porcine infarct
model the mean length and width of a VT isthmus were reported as
16.4± 7.2 mm and 7.4± 2.8 mm, respectively.13 Entrainment mapping
overestimated the size of the isthmus compared with activation map-
ping by 32± 18%.13 Similar dimensions have also been reported in
patients with conventional mapping systems (CARTO, Biosense
Webster) although with a wider range of values.24 In vivo MRI invaria-
bly suffers from partial volume effects due to insufficient spatial resolu-
tion whereby there is a loss of contrast between two adjacent tissue
types resulting in both tissue types occupying the same voxel. This
may limit the identification of scar BZ areas where the substrate for
VT is likely to be located. MRI with high spatial resolution (0.39 mm3)
has been used ex vivo in porcine infarct models to minimize partial vol-
ume effects and understand the fine 3D architecture of infarcts. The
VT re-entry isthmus was characterized by a small volume of normal
myocardium bound by scar tissue at the infarct BZ or over the
infarct.25 Rims of surviving myocardium surrounded by scar on ex vivo
imaging correlated on histology with normal myocardium bordered
by collagenous scar (Figure 1).26 The challenge is to develop high-reso-
lution imaging of this nature to guide VT ablation in vivo.
Relationship between electroanatomical
mapping defined scar and magnetic
resonance imaging-derived scar:
importance of bipolar voltage thresholds
Whilst some studies have reported a close correlation between
areas of MR-derived scar and low bipolar voltage,27 others have
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reported a greater degree of mismatch.14 Although a bipolar voltage
threshold of 1.5 mV is universally implemented to define ventricular
scar, this was defined using single-point ablation catheters and vali-
dated in ICM.28 Scar areas mapped using multi-electrode mapping
catheters (PentaRay) were 22% smaller using a 1.5 mV bipolar voltage
threshold compared to standard 3.5 mm catheters29 suggesting that
different catheters with various electrode sizes and inter-electrode
spacing may need catheter-specific thresholds for improved scar
characterization. The resolution of different mapping catheters could
partially explain areas of mis-match between EAM-defined scar and
MR-derived scar. Using ex vivo MRI as a gold standard, as bipolar spac-
ing increased, the optimal voltage threshold to detect MRI-defined
scar also increased, whilst statistically-derived 95% thresholds were
not fully sensitive for the detection of non-transmural scar.30 These
studies suggest that individualized patient-specific approaches may be
necessary for scar detection as strict voltage cut-offs may not neces-
sarily be reflective of scar biology in regions of tissue heterogeneity.29
Developments in magnetic resonance
techniques to improve substrate
assessment
Acquisition of high-resolution imaging is required to detect smaller
regions of scar and improve assessment of scar geometry in patients
undergoing VT ablation.31 3D LGE imaging can allow acquisitions
with a higher spatial resolution compared with 2D LGE but requires
prolonged scan durations. Longer scans can lead to changes in con-
trast agent concentration over time or reduced respirator navigator
efficiency due to irregular breathing patterns.31 The use of image
acceleration techniques such as compressed sensing has enabled
faster acquisition of 3D imaging of higher spatial resolution (1.2 mm3)
with acceptable scan duration, image quality, and comparable scar
characteristics to conventional 3D LGE.31 Parallel imaging with a
stack-of-spirals acquisition technique has also been used to enable
rapid 3D LGE acquisitions in a 12 heart beat-long breath-hold.32 3D
free-breathing self-navigating MR sequences have recently been
described to overcome the errors associated with respiratory naviga-
tor placement and irregular breathing patterns enabling high-
resolution visualization of scar distribution and superior delineation
of scar borders.33 A new technique to reconstruct a high resolution
image from multiple low resolution views of the same volume
(super-resolution reconstruction) has also shown a good agreement
with the bipolar voltage range of scar BZ.34 Further developments in
these techniques may allow faster imaging with higher spatial resolu-
tion and advance the ability of clinical MRI protocols to identify areas
of scar critical for re-entrant VT circuits.
The development of dark-blood LGE sequences as a technical sol-
ution to sub-optimal contrast between scar and blood pool offers
promise for improved substrate assessment. Dark-blood LGE
sequences have been described that simultaneously reduce normal
myocardium and blood pool SI whilst enhancing scar-blood contrast
and preserving scar-myocardium contrast.35,36 Given that a large pro-
portion of VTs appear to originate in the sub-endocardial region37
improved contrast between scar and blood pool may improve the
detection of substrate in these areas.
Limitations of magnetic resonance
imaging for substrate assessment in
patients with implantable cardioverter-
defibrillators
A major limitation to more widespread use of MRI in patients under-
going VT ablation is the presence of ICDs. Although potential safety
Figure 1 Ex vivo MRI and histology in a porcine chronic infarct heart using Masson’s trichrome staining. Top left panel—slice of ex vivo LGE image
demonstrating area of hyper-enhanced infarct with thin rim of normal myocardium at the endocardial border. Top right panel—Masson’s trichrome
stain of histological section demonstrating the area highlighted in the previous panel. Bottom right three panels—Three sections selected in the
infarct area and control area. Blue represents collagenous scar whilst pink represents normal myocardial tissue in non-infarcted regions. Adapted
with permission from Pashakhanloo et al.26 LGE, late gadolinium enhancement; MRI, magnetic resonance imaging.
MRI guidance for the optimization of VT ablation 3
Downloaded from https://academic.oup.com/europace/advance-article-abstract/doi/10.1093/europace/euy040/4951862
by King's College London,  rahul.r.mukherjee@kcl.ac.uk
on 23 March 2018
concerns have been raised when scanning patients with ICDs includ-
ing tissue heating adjacent to lead electrodes, induction of arrhyth-
mias, and alterations to device function,38 these risks appear to be
low.39 In addition to safety concerns, the presence of devices can also
provoke hyper-intense off-resonance artefacts mimicking scar tissue
affecting the reliability of LGE imaging. The introduction of wideband
LGE sequences however has improved the of artefact-free visibility
of myocardial segments and enhanced the diagnostic value of the MRI
exam in patients with implanted devices.40 A device-dependent imag-
ing strategy with a greater use of spoiled gradient-echo sequences
rather than conventional steady-state free precession imaging also
appears to improve the diagnostic image quality in patients with
devices.41,42
Despite the increasing use of MRI-compatible ICDs, not all centres
have established scanning protocols in place for patients with ICDs.
The in-plane spatial resolution of the wideband LGE techniques
reported have also been limited to 1.5 1.5 mm with a typical slice
thickness of 7–8 mm—this is unlikely to be sufficient for defining the
fine myocardial architecture responsible for VT.43 It also remains
unclear what effect prolonged exposure to MRI environments may
have on safety in patients with devices—e.g. during real-time MR-
guided interventions.
Image integration for ventricular
tachycardia ablation
Using data gained from preprocedural LGE-MRI, a number of studies
have attempted to perform periprocedural registration of scar tissue
with EAM through image integration (Table 1) and guide VT ablation
(Figure 2). Most of these reports were derived from retrospective
analyses on limited series of patients assessing the correlation
between MRI-derived scar and EAM.15,16,44–49 Some investigators
have assessed the accuracy of registration techniques50 or the use of
automated image analysis solutions for image integration51 and dem-
onstrated a high segmentation accuracy and lower inter-observer
variability compared with manual image analysis. More recently, a
growing number of studies have investigated the impact of image
integration on procedural management,52,53 acute or long-term
outcomes.54,55
The registration error reported within these studies have generally
been in the range of 3–5 mm (Table 1) whilst some investigators have
completed the registration process in real-time, rather than post hoc
allowing the electrophysiologist to focus mapping efforts to regions
of interest identified through imaging.56
In a prospective non-randomized study, Andreu et al.54 have
reported on the impact of image integration on acute and long-term
outcomes in VT ablation. A scar dechanneling technique was used to
perform substrate-guided ablation with 34% of patients having pixel
SI maps integrated into the navigation system during ablation. The
use of MR guidance resulted in a lower number of RF applications
and RF delivery time needed to achieve non-inducibility. There was
also a lower recurrence of VT reported in the CMR-aided ablation
group over a mean follow-up of 20± 19 months. The authors specu-
lated that these findings may have been due to identification of
arrhythmogenic substrate on CMR that was hidden on EAM and bet-
ter localization of subsequent target ablation sites.54 It is important to
note, however, that due to the lack of randomization in this study,
the control group had more dilated left ventricles with longer VT
cycle lengths compared to patients who underwent CMR-guided
ablation. In addition, 18% of patients who underwent CMR did not
have scar data post-processed for image integration due to either
poor image quality or improper acquisition. A retrospective analysis
in patients with dilated cardiomyopathy has also shown that the use
of preprocedural MRI was associated with improved procedural suc-
cess and improved survival free of a composite endpoint of VT recur-
rence, heart transplantation, or death over a median 7.6 months of
follow-up.55 This report compared an imaging group with a historical
control group where preprocedural imaging was not available. The
findings from these studies appear promising but prospective
randomized evidence is needed to assess if image integration can
truly improve the efficiency and efficacy of VT ablation.
Limitations of image integration studies
To date, all studies that have used image integration to guide proce-
dures have relied on MRI data acquired days or weeks prior to abla-
tion. Changes in the volume, orientation, and rhythm of the heart
between the time of the initial MRI and ablation procedure may lead
to inaccuracies in registering scar data from MR to EAM shells. Small
discrepancies in landmark identification on imaging and EAM can fur-
ther perpetuate registration errors. Translational changes due to
patient movement, cardiac or respiratory motion can also lead to dis-
crepancies between imaging and EAM.57 Potential registration errors
of even a few millimetres, as described in the image integration stud-
ies, could lead to misidentification of critical sites with potential con-
sequences on the efficacy of ablation.
The use of intra-procedural imaging with real-time MRI to guide
ablation may potentially overcome some of these limitations and
appears attractive. Magnetic resonance imaging can provide detailed
information on the cardiac chamber of interest as well as surrounding
structures. Respiratory and cardiac motion is also more accurately
assessed by MRI than any other imaging modality—compensating for
these factors during RF ablation could have potential implications for
the safety and efficacy of ablation.57
Real-time magnetic resonance-
guided electrophysiology and
ablation
Over the last decade, a number of centres have developed MR-
compatible ablation systems, reliable methods for visualizing the cath-
eter tip and application of a workflow to perform electrophysiology
procedures in high magnetic field environments.58 Diagnostic studies
have been performed in animal models to characterize intra-cardiac
electrograms within ventricular scar under real-time MR-guidance22
whilst ablation lesions have been assessed in real-time using dedi-
cated MR techniques.59 In order to develop these technologies and
establish procedural workflows all studies performed in patients to
date have focused on atrial flutter and ablation of the cavo-tricuspid
isthmus.60,61 However, the most logical application of real-time MRI-
guided electrophysiology would be in the setting of VT where the
benefits of substrate imaging are greater. Improved assessment of
4 R.K. Mukherjee et al.
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ventricular substrate with accurate real-time registration of imaging
to EAM data may overcome some of the limitations of current image
integration approaches. Further potential benefits of real-time MR-
guidance could include improved procedural guidance without expo-
sure to radiation and improved lesion visualization and titration of
therapy according to MR-defined end-points.
Intra-procedural guidance
A potential benefit of real-time MRI guidance over conventional EAM
is the ability to visualize soft tissue structures and access detailed
information on the chamber of interest and surrounding structures
to guide catheters to desired locations within the heart. Both passive
tracking (recognition of local susceptibility artefacts induced by
markers near catheter tip—e.g. dark spots) and active tracking (moni-
toring the active signal of a RF coil placed near the catheter tip to
determine position) have been used for accurate localization and vis-
ualization of catheters during real-time MR-guided interventions
(Figure 3).62,63
Dukkipati et al.64 first described the use of active catheter tracking
to navigate catheters into the left ventricle in swine, record intra-
cardiac electrograms and acquire 3D voltage maps. Further studies
have described the use of active tracking to perform trans-septal
puncture and left atrial access in an animal model.63,65,66 Both passive
tracking58 and active tracking60,61 have been used to guide atrial flut-
ter ablation in patients. There are as yet no studies describing the use
Figure 2 Image integration of MRI to EAM system for VT ablation. (A) Bipolar voltage map of a patient with ischaemic scar. Points 1–4 represent
electrograms with late diastolic components. (B) Pixel signal intensity map derived from LGE-MRI. Areas of dense scar are shown in red, healthy tis-
sue in pink whilst borderzone regions are shown in green/blue/yellow. (C) Registered LGE-MRI with EAM demonstrating corridors of conducting
channels within scar tissue. Reproduced with permission from Andreu et al.54 EAM, electroanatomical mapping; LGE, late gadolinium enhancement;
MRI, magnetic resonance imaging; VT, ventricular tachycardia.
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of active tracking in patients undergoing VT ablation and although sig-
nificant logistical challenges exist, this is a potential avenue of future
work.
Ablation lesion assessment
Magnetic resonance imaging can be used to visualize lesions in real-
time, acutely (Figure 4) and assess chronic injury. Lardo et al.67 first
described the use of MRI to characterize the spatial and temporal
extent of ablation lesions in mongrel dogs. Subsequent work has
described distinct phases of signal enhancement over time of
contrast-enhanced lesion imaging68 and the optimal timing of late-
enhancement imaging to accurately predict chronic lesion volume.69
During real-time MR-guided interventions, contrast can only be given
once however, necessitating the development of non-contrast
sequences for lesion visualization. Both T1-weighted and T2-
weighted non-contrast techniques have been described to visualize
ablation lesions with high-signal areas in lesion cores and surrounding
low intensity rims corresponding on histopathology to central tissue
necrosis and a transition zone, respectively.70
The ability to clearly visualize ablation injury using MRI could offer
a potential new procedural endpoint to judge if sufficient ablation has
been performed. In a porcine model of chronic MI, the ability to
induce VT was associated with a substantially larger zone of hetero-
geneous tissue. Animals then underwent ablation with at least one
lesion delivered in the heterogeneous zone. A repeat MRI and EP
study performed 1 week after ablation showed that animals that
were still inducible had remaining areas of heterogeneous tissue due
to incomplete ablation. In two animals without remaining heteroge-
neous tissue on MRI, VT was not inducible.71 This is in keeping with
clinical experience where an extensive substrate-based approach tar-
geting all abnormal electrograms has been reported to be superior,
in terms of VT recurrence, to limited ablation strategies targeting
only clinical and stable VTs.72 Assessment of remaining heterogene-
ous tissue on MRI following ablation may prove to be a useful imaging
endpoint during real-time MRI-guided ablation.
Visualization of ablation lesions hours or weeks after a procedure
does not allow modification of the ablation strategy at the index pro-
cedure. Just as the electrophysiology community seeks improved
lesion assessment techniques, there is growing interest in MR-based
techniques to visualize lesions in real-time informing RF delivery and
potentially improving the efficacy of ablation. MR-thermometry using
the proton resonance frequency shift (PRFS) has emerged as a useful
technique in this regard. Protons are surrounded by electrons which
act to disturb the local magnetic field during MR scanning.57
Following ablation there is an increase in temperature, breaking of
inter-molecular hydrogen bonds and an increased density of free
electrons. The change in PRFS using phase mapping has been used to
quantify tissue temperature changes during ablation and demon-
strated in mongrel dogs.73 More recently, in an ovine model, endo-
cardial ablation could be clearly monitored in real-time using
Figure 3 MRI for intra-procedural guidance in a porcine model during real-time intervention. Top panels and bottom left panel—three orthogonal
slices through the left ventricle. The red catheter icon represents the actively tracked catheter during epicardial ablation. Bottom right panel—3D
reconstructed shell of cardiac chambers (red, left ventricle; orange, right ventricle; blue, left atrium) to guide navigation based on 3D whole heart MRI
acquired at the time of procedure. The points represent regions where an ablation lesion has been delivered. MRI, magnetic resonance imaging.
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MR-thermometry with thermal lesion dimensions highly correlated
to measurements at gross macroscopy.74
Online monitoring of cardiac temperature during real-time MR-
guided ablation appears promising, but there are several challenges
to overcome including adequate compensation for artefacts due to
respiratory or cardiac motion, assessing accuracy of the technique
during irregular heart rhythms and investigating the ability of the tech-
nique to predict chronic transmural injury. This tool however, repre-
sents an interesting step in exploiting acute physiological changes
during ablation using MR to potentially titrate RF energy delivery.57
Further validation work is warranted to see if the technique is feasible
in patients during real-time MR-guided ablation.
Other interventional considerations and
potential challenges for magnetic
resonance-guided ventricular tachycardia
ablation
Assessment of substrate and delivery of RF energy are only two com-
ponents of a catheter ablation procedure for VT. Epicardial access or
emergency pericardiocentesis may be required during VT ablation—
a previous report in a porcine model described the feasibility of real-
time MRI-guided subxiphoid pericardial access and pericardiocentesis
using passive needle devices75 but no clinical studies to demonstrate
safety have been performed to date.
Transcatheter needle chemoablation to target intra-mural sub-
strate has generated interest to improve the efficacy of ablation in
selected patient cohorts. In this regard, Rogers et al.76 have delivered
chemoablation with ethanol or acetic acid under real-time MRI guid-
ance in swine with immediate visualization of lesions and subsequent
EAM confirmation of conductive isthmus disruption which appears
promising.
The advent of novel emerging technologies such as stereotactic
body radiation therapy (SBRT) to deliver ‘radioablation’ and create
electrically inert tissue further increases the importance of accurate,
non-invasive characterization of substrate. In a recent case series,
SBRT was used to deliver catheter-free radioablation to patients with
refractory VT with a marked reduction in the burden of VT in all
patients.77 The development, refinement and validation of real-time
MRI techniques could be a critical component in developing such
novel therapies.
There is currently a lack of commercially available MR-compatible
external defibrillator systems. The need to defibrillate urgently during
VT ablation and the potential time required to evacuate a patient
from a MR scanner bore and perform external defibrillation is a major
safety hurdle that needs to be overcome in order to facilitate the
uptake of higher-risk MR-guided ablation procedures. In this context,
a recent report has described a prototype MR-conditional defibrilla-
tion system to successfully defibrillate swine inside and outside a
scanner bore.78 Electrical cardioversion during a procedure will inevi-
tably result in patient movement and subsequent changes in the posi-
tion of the heart relative to reconstructed anatomical shells. As is the
case with EAM systems, repeated real-time MR confirmation scans
may be necessary to update anatomical shells and maintain accurate
registration.58 New acquisitions with 3D reconstructions would pro-
long what is already likely to be a long procedure.
Contemporary electrophysiology procedures in complex arrhyth-
mias are increasingly guided by 3D EAM systems. Current generation
MR-compatible catheters cannot achieve the same resolution as mul-
tipolar mapping catheters used with high-resolution 3D EAM sys-
tems.79 A potential workflow to performing real-time MRI-guided
intervention could therefore be to perform a conventional electro-
physiological assessment followed by moving the patient into the MRI
scanner for intra-procedural assessment of imaging substrate, guid-
ance with active tracking, ablation lesion delivery and lesion assess-
ment under real-time MR guidance. Development of such a
workflow will require rapid, automated segmentation and registra-
tion tools and could allow the benefits of conventional EAM assess-
ment to be combined with real-time imaging but can realistically only
be performed in hybrid X-ray and MRI catheter laboratories.
Radiofrequency-induced tissue heating is an important safety con-
cern particularly when scanning patients with ICDs and it remains
unclear what the safety implications may be when performing long
Figure 4 Acute assessment of ablation lesions using non-contrast T1-weighted MRI in a porcine model. A hyper-intense region is seen in the myo-
cardium corresponding to the location of ablation lesion delivery (white arrows). The advantage of non-contrast techniques to assess ablation lesions
would be to allow repeated assessments during an index procedure and potentially perform additional ‘top-up’ ablation if required. MRI, magnetic
resonance imaging.
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procedures under MRI guidance in these patients. In patients with
devices that are not MRI-compatible, alternative imaging modalities
such as cardiac computed tomography to assess VT substrate (wall
thinning and scar) may be more appropriate.80 In order to enable fast
image analysis during real-time MR-guided interventions, rapid seg-
mentation, registration and visualization platforms are required,
which are currently under active development.81
Other challenges that need to be addressed include safe anaesthe-
sia and monitoring of patients and ensuring good communication
between the electrophysiologist in the MR environment and other
healthcare professionals involved in the procedure. Although some
of these issues have been navigated in the setting of atrial flutter abla-
tion, performing VT ablation under real-time MR-guidance adds a
new dimension of complexity. There is also potentially a steep learn-
ing curve for an electrophysiologist in handling and manoeuvring new
MR-compatible catheters as well as interpreting MR images for which
they may have received little training. Although there is much interest
within the electrophysiology community in real-time MR-guided
interventions, there are relatively few centres with the resources,
expertise and technologies to perform such interventions.57
Future perspectives
Despite the substantial progress that has been made on the use of
MRI to guide VT ablation, there is insufficient evidence at present to
suggest that the use of imaging can add value to clinical outcomes.
Although observational, non-randomized studies suggest that image
integration may impact on procedural outcomes, well-designed pro-
spective randomized studies are needed to assess the true impact of
image integration as well as evaluate potential mechanisms of any
benefit. Further studies evaluating new MRI techniques to distinguish
between arrhythmogenic and non-arrhythmogenic scar at high spatial
resolution may have downstream effects on improving patient selec-
tion for catheter ablation and increased standardization of ablation
strategies based on imaging evaluation. Increased standardization in
the management of these patients may help reduce workflow dis-
crepancies across centres and potentially impact on the efficacy of
ablation.
Real-time MRI-guided electrophysiology is a field still in its relative
infancy. Further technical development and validation studies are
required to improve substrate localization in real-time, corroborate
the accuracy of procedural guidance with active tracking and assess
the ability of real-time techniques to predict durable ablation lesions.
Pre-clinical and clinical studies will be required to standardize work-
flows for real-time MRI-guided interventions and ultimately com-
pared with conventional VT ablation in order to demonstrate added
value.
Conclusion
There has been significant progress in the use of MRI to facilitate sub-
strate assessment, integrate data into clinical EAM systems, guide
procedures and assess ablation lesions. There is however a lack of
prospective randomized evidence to assess if image integration using
MR improves the efficacy or efficiency of ablation. There are also a
number of technical limitations to using an image integration
approach to guide VT ablation. The possibility of real-time MR-guided
ablation is intriguing but to date has only been studied in pre-clinical
models and patients undergoing atrial flutter ablation. Catheter abla-
tion for VT is likely to reap the greatest benefits from developments
in real-time MR-guided electrophysiology but significant challenges
need to be addressed prior to clinical studies in patients.
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